Behzadan, affiliated with the Department of Civil, Environmental and Architectural Engineering and the Institute of Behavioral Science at CU Boulder, leads a team that seeks to unravel the intricacies of trust and artificial intelligence. Their efforts have resulted in a structured framework intended to bolster the trustworthiness of AI tools that impact human lives. The implications are profound: as AI systems integrate deeper into our daily existence, fostering trust is vital for their acceptance and utilization.

In their recent study, highlighted in the journal “AI and Ethics,” Behzadan and his research colleague, Ph.D. student Armita Dabiri, delve into the fundamental attributes of trustworthy AI. Their research culminates in the development of a conceptual AI tool that encapsulates critical elements of trustworthiness. The duo articulates that trust, often initiated through vulnerability, can be seamlessly translated from human-to-human relationships to those involving humans and technology. This perspective invites a reassessment of how society interacts with emerging AI technologies.

Behzadan meticulously examines the foundational aspects of trust in artificial intelligence, particularly focusing on applications within the built environment. Whether it is navigating the complexities of autonomous vehicles, optimizing smart home security, or enhancing public transportation systems, understanding how trust is formed is crucial. The historical context shows that trust, integral to human cooperation and collaboration, has evolved. From ancient societies forming bonds based on mutual reliance to modern perceptions of AI as potentially alien or challenging, the dynamics of trust have retained their significance.

One of the central tenets of Behzadan’s research is that trust is subjective, varying extensively among individuals based on personal experiences, values, cultural backgrounds, and intrinsic cognitive frameworks. This inherent variability means that even the most reliable AI systems could inspire disparate levels of trust among users. Developers, therefore, face the challenge of tailoring AI technologies to meet diverse user needs and preferences, ensuring that technological advancement does not falter due to misunderstandings or a lack of connection.

Behzadan outlines the importance of reliability, ethics, and transparency in the design of trustworthy AI systems. In contexts where life-altering decisions are made, such as healthcare or autonomous transport, users must be assured of the safety and security of the technology at hand. Moreover, transparency regarding data usage and algorithmic decision-making can significantly alleviate concerns surrounding privacy and control. In situations where users feel observed or manipulated, their willingness to trust diminishes, further emphasizing the need for clear communication about how AI technologies function.

Context is also crucial in establishing trust in AI systems. Behzadan and Dabiri’s work presents an innovative AI tool titled “PreservAI,” which exemplifies sensitivity to contextual nuances. In practical applications, such as when various stakeholders – engineers, urban planners, and government officials – confront the building of a historical structure, the ability of AI to navigate competing priorities effectively can make or break trust. This tool is designed to integrate stakeholder feedback and evaluate various outcomes, demonstrating that AI can abstract critical contextual knowledge much like humans do while collaborating.

User experience plays a significant role in building trust. Technologies that facilitate interactions and allow feedback create an environment in which users can engage actively with AI systems. The importance of ensuring an intuitive, user-friendly design cannot be overstated. Behzadan explains that if users have autonomy in their interactions with AI, they are more likely to develop a rapport with the system, further solidifying their trust. This engagement becomes even more vital when considering how trust can shift, sometimes erratically, depending on experiences with technology.

Trust is inherently dynamic and can fluctuate based on experiences or external events. For example, a potential rider’s enthusiasm for a self-driving taxi may wane following news of accidents involving autonomous vehicles, leading to a crisis of confidence. Yet Behzadan remarks on the potential for rebuilding that trust through improved design and outcomes. The case of Microsoft’s “Tay” chatbot illustrates this point, as the initial failure prompted the company to launch “Zo,” which incorporated lessons learned from the earlier missteps. This iterative approach to trustworthiness is essential for the sustainable development of reliable AI technologies.

The journey toward fostering trust in AI systems is undoubtedly complex, laden with risks. Users must often relinquish some control and share personal data for these systems to operate efficiently. In turn, these AI systems learn and adapt, potentially becoming more effective over time. The crux lies in balancing these elements, ensuring that users feel comfortable and secure in sharing their data while maximizing the utility of AI innovations.

Amir Behzadan emphasizes that the potential for AI is vast; when people trust these systems enough to engage with them meaningfully, it catalyzes an evolution toward more personalized and effective support. This promises not just a technological revolution but also a transformation in the quality of life, as individuals experience tailored solutions that cater to their unique needs. The path forward will require continued dialogue and exploration into the mechanisms of trust, ensuring that as AI becomes more prevalent, it becomes increasingly benign, facilitating a partnership that ultimately empowers users.

This multifaceted exploration into trust and artificial intelligence highlights a pressing issue of our time. As we stand at the brink of widespread adoption of autonomous technologies, understanding the foundational aspects of trust and implementing reliable systems could be the differentiator between acceptance and reluctance. Success in this realm will pave the way for an era of collaboration between humans and AI that enhances not just technological efficacy but the very fabric of societal interactions.

Ultimately, as we witness the evolution of self-driving taxis and other autonomous systems, embracing a framework fortified by trust could lead to breakthroughs that enhance our day-to-day experiences, reducing the skittishness surrounding prevalent AI technologies. With insights from Amir Behzadan and his research efforts, society may harness not only the tools of tomorrow but also the promise they hold for a more interconnected future.

Subject of Research: Trust in Artificial Intelligence and Self-Driving Technology
Article Title: Factors influencing human trust in intelligent built environment systems
News Publication Date: 15-Aug-2025
Web References: AI and Ethics
References: doi:10.1007/s43681-025-00813-6
Image Credits: University of Colorado Boulder

Keywords

Artificial Intelligence, Civil Engineering, Trust in Technology, Autonomous Vehicles, User Experience, Ethical AI.

The editorial, authored by Dr. David Waterhouse, Chief Innovation Officer of Oncology Hematology Care and Editorial Board Member of AI in Precision Oncology, along with co-author Terence Cooney-Waterhouse from VandHus LLC, underscores that trust is not a mere byproduct of technological innovation—it is a foundational prerequisite for meaningful integration. Their analysis explores the dual challenges faced by patients and clinicians: patients grapple with concerns over privacy breaches, algorithmic bias, and opaque decision-making, while physicians question the clinical validation and interpretability of AI models before they can fully embrace them in treatment workflows.

Such concerns are not unfounded. AI systems, especially those employing complex neural architectures like deep learning and artificial neural networks, often operate as "black boxes," making it difficult for end-users to comprehend how specific inputs translate to clinical recommendations. This opacity threatens the transparency essential in medical decision-making, where accountability and explainability are paramount. Moreover, the risk of bias ingrained in datasets—owing to demographic disparities or skewed clinical trial populations—can inadvertently perpetuate health inequities if not rigorously addressed.

To overcome these barriers, the authors advocate for robust governance frameworks that prioritize data stewardship, algorithmic transparency, and stakeholder engagement. Specifically, their call to action involves implementing transparent model reporting standards that elucidate the training datasets, validation procedures, and limitations of AI systems. Incorporating rigorous clinical trials and post-deployment surveillance ensures that AI tools meet the highest standards of safety and efficacy. Furthermore, fostering meaningful involvement from patients, clinicians, ethicists, and policymakers during the development lifecycle can mitigate ethical pitfalls and support equitable access.

Douglas Flora, MD, Editor-in-Chief of AI in Precision Oncology, poignantly likens the assimilation of AI into oncology care to the introduction of a new colleague within an established clinical team. Trust, he notes, cannot be handed over implicitly; it must be earned through consistent demonstration of reliability, transparency, and clinical utility. This analogy resonates particularly within oncology, where decisions bear profound life-and-death consequences, and the stakes for clinical accuracy and patient safety remain exceedingly high.

From a technical standpoint, the deployment of AI in oncology encompasses multiple modalities, including diagnostic imaging interpretation, clinical decision support systems, and risk stratification through molecular and genetic data analysis. Machine learning algorithms analyze vast datasets spanning histopathology images, radiographic scans, electronic health records, and genomic profiles to identify patterns imperceptible to human observers. However, the translation from algorithmic output to actionable clinical insights requires interfaces that clinicians can trust and readily interpret.

The editorial highlights that one pivotal avenue for building confidence lies in enhancing transparency through explainable AI (XAI) techniques. XAI seeks to provide interpretable justifications for AI-driven conclusions, enabling clinicians to understand the rationale behind recommendations and detect potential errors. By integrating user-friendly visualization tools and adjustable parameters, these systems can empower oncologists to tailor AI assistance to individual patient circumstances, fostering greater acceptance.

Compounding the technical challenges are ethical considerations intrinsic to AI adoption in healthcare. Issues surrounding patient consent for data usage, safeguarding against unintended biases, and ensuring equitable distribution of AI-enabled care demand rigorous scrutiny. Establishing ethical frameworks and standards led by interdisciplinary collaborations is fundamental to fostering societal trust and preventing the marginalization of vulnerable populations.

Moreover, equitable access to AI innovations remains a pressing concern. The editorial stresses that without intentional policies and investments, there is a risk that advanced AI tools may concentrate within well-funded institutions, exacerbating disparities in cancer diagnosis and treatment outcomes. Thus, ensuring scalability and affordability, coupled with extensive clinician training programs, will be critical for democratizing AI benefits across diverse healthcare settings.

Critically, the integration of AI is not meant to supplant human expertise but rather to augment oncologists’ clinical acumen. AI can handle complex data assimilation and pattern recognition at unparalleled scales, but final judgments require human empathy, contextual understanding, and ethical reasoning. This paradigm positions AI as an essential ally rather than an autonomous decision-maker, reinforcing collaborative care models centered on patient well-being.

Dr. Waterhouse and his colleagues also advocate for ongoing education and transparent communication with patients regarding AI’s role in their care. Recognizing and addressing patient concerns through clear dialogue about data protections, algorithm validation, and AI limitations can alleviate apprehensions, thereby enhancing shared decision-making. Cultivating digital health literacy among patients emerges as a pivotal element in bridging the trust gap.

In conclusion, the journey towards fully harnessing AI in clinical oncology mandates a multifaceted approach encompassing technical rigor, transparent governance, ethical mindfulness, and robust stakeholder engagement. As Dr. Flora emphasizes, trust is earned through demonstrated reliability and consistent, transparent results. By embracing these principles, the oncology community can transform AI from a contested innovation into a trusted partner, driving precision medicine forward and ultimately improving cancer patient outcomes worldwide.

AI in Precision Oncology, the journal publishing this insightful discourse, stands as the dedicated platform championing advancements at the nexus of artificial intelligence and cancer care. Spearheaded by Dr. Douglas Flora, the journal convenes a global network of experts driving forward research in machine learning, data analysis, clinical imaging, and beyond, fostering rapid dissemination of breakthroughs that promise to redefine oncology practice for the better.

Subject of Research: People
Article Title: Bridging the Trust Gap in Artificial Intelligence for Health care: Lessons from Clinical Oncology
News Publication Date: 22-Apr-2025
Web References:

• https://home.liebertpub.com/publications/ai-in-precision-oncology/679
• https://www.liebertpub.com/doi/10.1089/aipo.2025.0001
  References: 10.1089/aipo.2025.0001
  Image Credits: Mary Ann Liebert, Inc.
  Keywords: Cancer, Logic based AI, Artificial intelligence, Machine learning, Deep learning, Artificial neural networks, Neural net processing, Health and medicine, Clinical studies, Clinical imaging, Medical diagnosis, Health care, Data analysis, Data visualization, Natural language processing, Informatics, Cancer risk, Cancer patients